Inactive Instrument

Bio-Works Technologies AB (publ) Stock Nasdaq Stockholm

Equities

SE0007387089

Medical Equipment, Supplies & Distribution

Sales 2021 56.36M 5.19M Sales 2022 41.32M 3.81M Capitalization 736M 67.86M
Net income 2021 -12M -1.11M Net income 2022 -45M -4.15M EV / Sales 2021 15.2 x
Net cash position 2021 103M 9.47M Net cash position 2022 65.88M 6.07M EV / Sales 2022 16.2 x
P/E ratio 2021
-66.3 x
P/E ratio 2022
-16.4 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 56.22%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 47 20-06-25
Founder - 05-12-31
Director of Finance/CFO - 23-07-31
Members of the board TitleAgeSince
Corporate Officer/Principal 71 13-09-23
Director/Board Member 59 20-05-14
Director/Board Member 50 20-05-14
More insiders
Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
More about the company